Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Observation × CNS × Clear all

Status

Completed 7 Recruiting 4 Active not recruiting 2 Unknown 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 10 Breast 3 Plasma cell 2 Gynecologic 2 Genitourinary 2 Thoracic 1 Other neoplasm 1 Lymphoid 1 Head & Neck 1 CNS 1

Conditions

Hemangioma, Cavernous, Central Nervous System 1

Interventions

Temozolomide 61 Radiotherapy 49 Carboplatin 23 Bevacizumab 19 Radiosurgery 17 Cisplatin 17 Vincristine 16 Etoposide 16 Cyclophosphamide 16 Surgical Procedures, Operative 13 Magnetic Resonance Spectroscopy 13 Chemotherapy, Adjuvant 10 Melphalan 9 Lomustine 9 Radiation 8 Erlotinib Hydrochloride 8 apatinib 7 anlotinib 7 Pemetrexed 7 Filgrastim 7 Drug Therapy 7 3-Iodobenzylguanidine 7 Peripheral Blood Stem Cell Transplantation 6 Irinotecan 6 Carmustine 6 Blood Specimen Collection 6 camrelizumab 5 aumolertinib 5 Thiotepa 5 Neoadjuvant Therapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03467295 2018-03-19

TOUCH

First Affiliated Hospital of Fujian Medical University

Hemangioma, Cavernous, Central Nervous System

Data powered by HemOnc (CC BY 4.0) Colophon ⚡